Search for: "Sharp v. Merck " Results 61 - 80 of 201
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jan 2019, 6:32 am by Elizabeth McCuskey
The Supreme Court opened its January session Monday morning with argument in Merck Sharp & Dohme Corp. v. [read post]
4 Nov 2017, 5:47 am
They look a little different, but the Dutch Supreme Courtsays that they should be treated just the same  Yesterday afternoon, the AmeriKat's Dutch friend, Professor Tobias Cohen Jehoram (De Brauw Blackstone Westbroek) sent her, hot of the press, a copy of the Dutch Supreme Court's decision in Merck Sharp & Dohme v Teva delivered yesterday morning. [read post]
24 Mar 2022, 11:25 am by Tom Lamb
Supreme Court made a ruling on the federal preemption legal issue in these Fosamax cases in May 2019 (see Merck Sharp & Dohme Corp. v. [read post]
23 May 2019, 3:29 am by Edith Roberts
Subscript Law offers a graphic explainer for Monday’s opinion in Merck Sharp & Dohme v. [read post]
9 Jun 2020, 9:56 am by Dennis Crouch
by Dennis Crouch Merck Sharp & Dohme Corp. v. [read post]
21 Jun 2021, 1:18 pm by Sean Wajert
  The Supreme Court discussed in Wyeth and later clarified in Merck Sharp & Dohme Corp. v. [read post]
26 May 2021, 8:40 pm by Adeline Chong
Written by Professor Yeo Tiong Min, SC (honoris causa), Yong Pung How Chair Professor of Law, Yong Pung How School of Law, Singapore Management University In Merck Sharp & Dohme Corp v Merck KGaA [2021] SGCA 14, a full bench of the Singapore Court of Appeal addressed the limits of transnational issue estoppel in Singapore law, and flagged possible fundamental changes to the common law on the recognition and enforcement of foreign judgments in Singapore. [read post]
4 Oct 2022, 11:47 am by Holman
Merck Sharp & Dohme Corp., 2022 WL 4541687 (Fed. [read post]
9 Mar 2012, 3:06 pm by Tom Lamb
Merck Sharp & Dohme Corp., ATL-L-3394-11 (MT), which is currently ongoing in a New Jersey state court, with Judge Carol Higbee presiding -- that the osteonecrosis of the jaw (ONJ) which Mrs. [read post]
19 Mar 2012, 4:16 am
Judge Birss QC assures us that his decision in Merck Sharp Dohme Corp & Anor v Teva Pharma BV & Anor [2012] EWHC 627 (Pat), relating to an application by Bristol-Myers Squibb for an interim injunction pending trial, raises no issue of principle, but he does provide an enlightening discussion of how to address some issues of fact that are common in an application for a quia timet injunction, including a review of the European case law. [read post]
10 Jan 2019, 10:00 pm by DONALD SCARINCI
Below is a brief summary of issues before the Court last week: Merck Sharp & Dohme Corp. v. [read post]
8 Nov 2018, 1:06 am by Ilarion Tomarov
Ilarion TomarovThe Ukrainian Supreme Court in Merck Sharp & Dohme Corp v Aurobindo Pharma Limited has recently introduce a bold approach to applying interim injunctions in disputes between originators and generics over the registration of patented pharmaceuticals. [read post]